K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity
about
The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brainpH regulation and beyond: unanticipated functions for the voltage-gated proton channel, HVCN1Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cellsKv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseasesPotassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal diseasePotassium channels, memory T cells, and multiple sclerosisTargeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseasesThe antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blockerA microarray platform-independent classification tool for cell of origin class allows comparative analysis of gene expression in diffuse large B-cell lymphomaHypercholesterolemia suppresses Kir channels in porcine bone marrow progenitor cells in vivo.Presence of HSV-1 immediate early genes and clonally expanded T-cells with a memory effector phenotype in human trigeminal ganglia.Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthmaDifferential molecular information of maurotoxin peptide recognizing IK(Ca) and Kv1.2 channels explored by computational simulation.A novel platform to produce human monoclonal antibodies: The next generation of therapeutic human monoclonal antibodies discovery.Intermediate-conductance calcium-activated potassium channels participate in neurovascular coupling.NS6180, a new K(Ca) 3.1 channel inhibitor prevents T-cell activation and inflammation in a rat model of inflammatory bowel disease.Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1.Targeting potassium channels Kv1.3 and KC a 3.1: routes to selective immunomodulators in autoimmune disorder treatment?Systemic effects of ingested Lactobacillus rhamnosus: inhibition of mast cell membrane potassium (IKCa) current and degranulation.Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytesPotassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease.Loureirin B, an essential component of Sanguis Draxonis, inhibits Kv1.3 channel and suppresses cytokine release from Jurkat T cellsThe Lymphocyte Potassium Channels Kv1.3 and KCa3.1 as Targets for Immunosuppression.Toxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune DiseasesN-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke.Use of Kv1.3 blockers for inflammatory skin conditions.Therapeutic potential of KCa3.1 blockers: recent advances and promising trends.The use of 4-aminopyridine (fampridine) in demyelinating disorders.Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's DiseaseDevelopment of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseasesRituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptorsStructural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore.Cells move when ions and water flow.Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaquesAltered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosusIon channels in innate and adaptive immunityProton channels in non-phagocytic cells of the immune system.The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling
P2860
Q24300087-296B635A-49B8-4D82-9A08-456FF0AC29BDQ24534346-0B7BB118-F3A8-477B-9C89-F74299A1565CQ24606285-00768E57-C03C-46BC-A0E9-EC397135A4D3Q24671130-C92B2857-1482-426B-A111-BE6652F9E206Q27684056-0264E393-C3D5-4282-81EE-68F88E59C5F0Q28252713-3194C96E-97EC-405B-8582-42FEBE4EC6AFQ28281365-3893FFF4-4A65-419F-92A5-E9DFB9711897Q28303760-2B0CE60B-B7FD-4E09-8C3B-A720A9A7C2AEQ28482737-10F8DEB9-0842-43FA-AED2-B885C4F9A7ABQ30485971-BB7C8CF6-2B4A-41C4-BF47-11C620D96206Q33283815-12BD1CE6-0C02-4015-8882-5C6A84A34940Q33296893-793EB7AA-CDE3-4DFB-9D67-579A7D79ED49Q33556185-2AC5514D-BF5D-4C36-BC1D-2BA97E520E52Q33801747-7F6ECDF7-6565-4801-BF96-239757F186CAQ33810163-94F51B8B-1F7D-4FD3-9630-6875EB1A60C5Q33877765-CA46C3C3-B9F1-48AE-A0E7-CE6C96D3DB9EQ34293957-A8E0B65E-B676-411F-8530-AD05BF9E04E3Q34298326-2670B773-1BFC-40DB-BF27-AE315B3F5D97Q34343254-C0D49D50-9A8B-4DA8-ADC2-B97F8293761AQ34345878-4D4344A9-0E5B-4975-8549-42C2A30988C8Q35022931-86600109-57A7-464B-93F9-7C64F5E6BB5FQ35470763-2F0721A2-5E6D-42ED-9FDA-19A20AEFF525Q35563291-4BBD520B-8687-4C46-89D1-7F41AD5DA200Q35660234-038E60B3-52D9-4100-923F-105BF43619EBQ35662935-651B1FE1-5EB7-49E4-895F-52D8BD7ABEFBQ35756367-1A05C65C-5F2D-4797-8E13-4C8B25990426Q35880549-B63154EE-1762-4646-A8F1-AED0D8A79CF2Q35915882-EAB89EA2-850D-4763-A06C-3549960BA085Q35944615-A8113260-F597-4117-AEAE-459548970C5CQ35981034-53D30150-903C-46FE-AE7F-D9F3B5DF3931Q35999547-C1EFAC7E-9A30-4C9E-B0C6-2DBAEFF303BBQ36097325-5F4C5B19-28C4-446B-A445-6F55BDDCBA84Q36102906-6428AAC9-FE0F-40C8-8191-4CFBDDF3025DQ36261948-4B9298C5-9D38-42CE-9703-80307D846DCEQ36615011-5866FE76-C206-4D3A-8E65-F550B986887BQ36666549-718E7743-9800-4B16-AA66-84D17B8CA150Q36755899-7CDDBB7D-7B94-4C8D-9563-F2A4E66ADA8DQ36769825-A45842BD-932A-4502-8E89-E37E7C3E5E13Q36860532-85FC6354-873F-4526-A70A-4D5508BE19A4Q36890651-511FAACC-8BED-4DFE-BF02-B399BDBD4A9E
P2860
K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
K+ channel expression during B ...... unomodulation and autoimmunity
@ast
K+ channel expression during B ...... unomodulation and autoimmunity
@en
K+ channel expression during B ...... unomodulation and autoimmunity
@nl
type
label
K+ channel expression during B ...... unomodulation and autoimmunity
@ast
K+ channel expression during B ...... unomodulation and autoimmunity
@en
K+ channel expression during B ...... unomodulation and autoimmunity
@nl
prefLabel
K+ channel expression during B ...... unomodulation and autoimmunity
@ast
K+ channel expression during B ...... unomodulation and autoimmunity
@en
K+ channel expression during B ...... unomodulation and autoimmunity
@nl
P2093
P3181
P1476
K+ channel expression during B ...... unomodulation and autoimmunity
@en
P2093
Heike Wulff
K George Chandy
Michael Pennington
P304
P3181
P356
10.4049/JIMMUNOL.173.2.776
P407
P577
2004-07-15T00:00:00Z